Moderna’s mRNA flu shot trial results are in

…and there are danger signals

Despite aggressive vaccination campaigns against the flu, it is still with us, and always will be. It should be obvious to everyone by now that flu shots cannot prevent recipients from getting the flu. The propagated lie is that the shot prevents severe flu symptoms by creating antibodies that will attach to flu viruses when the recipient gets infected, supposedly blocking them from entering other cells. This idea would work if the antibodies were able to recognize all protein parts of the flu virus and strongly bind to them. But they don’t. You can’t get that kind of protection by injecting some protein parts of the virus or messages to make proteins. The antibodies that result from these injections are suboptimal and create all sorts of problems including two distinct types of antibody dependent enhancement that you can learn about here.

The injections also cause autoimmune issues as was evident in this trial. The only way to get full robust antibody protection is by experiencing a natural infection, where the invader comes through the epithelial barrier, allowing the immune cells to recognize the whole thing and build antibodies against all protein parts of it, not just a piece of it.

The problem in our society is that people are afraid of experiencing flu symptoms. They are afraid that it will kill them. It is true that severe flu symptoms can be life threatening, but not all exposures result in severe symptoms. Life threatening circumstances associated with respiratory infections like the flu will arise if extensive tissue damage occurs in the air sacs of the lungs, resulting in fluid leakages and subsequent pneumonia. This may happen in people with immunosuppression or over-reactive immune responses. Even in severe cases with pneumonia, alveolar tissue damage, inflammation, and impaired gas exchange, emergency interventions can prevent respiratory failure. People forget the value of common-sense prevention and early treatment, and are more likely to subject themselves to an injection if they believe it will protect them. Injections do not prevent infections, nor do they prevent symptoms, and that fact is clear in the trial results that were published here.

This was a 3-phase trial. All phases are complete, but the results for phase 3 have not been published yet. Phase 1 used a saline injection as a placebo. Phase 2 did not use a placebo. All 501 people in phase 2 were injected with active ingredients. Phase 2 used a comparative injection of a traditional flu vaccine called Afluria by Seqirus as a comparator, looking to see if Moderna’s mRNA injection would result in a more robust antibody response. The mRNA injection did end up making more antibodies, but that is not necessarily a good thing.

Phases 1 and 2 looked for safety signals and antibody responses. Moderna’s published press releases say there were no safety signals, but that is a lie. Phase 1 included 180 people, all healthy and aged 18 or older. The placebo, a saline injection, was administered to 45 people. In the vaccinated group, 45 got 50 micrograms of mRNA-1010, 45 got 100 micrograms, and 45 got 200 micrograms. Phase 2 added 501 more healthy people aged 18 and older. 53 got Afluria, and the rest of them evenly divided got either 25, 50, or 100 micrograms of mRNA-1010. According to the report, “One participant in the mRNA-1010 100-µg group in Part 2 of the study died due to cardiac arrest. This adverse event was considered by the investigator as unrelated to the study vaccination.” The name of the investigator is not revealed.

Adverse events are graded as 1 (mild), 2 (moderate), 3 (severe), 4 (potentially life-threatening) and 5 (death). One person in the placebo group reported a severe adverse reaction. Four people in the Afluria group reported a severe adverse reaction. 94 people who were injected with 50 micrograms or more of mRNA-1010 reported severe adverse reactions. So, no safety signals according to Moderna. There is nothing to see here.

Adverse reactions will always occur with mRNA injections because the proteins they code for are bioactive proteins. Bioactive proteins will attach to cellular receptors, and this will always result in immune responses that will destroy those cells. The mRNA-1010 in this Moderna concoction is the message to make the Hemagglutinin (HA) protein on the flu virus. The HA protein is what the flu virus uses to enter human host cells. So, why don’t they make other proteins on the virus that are not bioactive, like nucleocapsid proteins? Well, if they did that, the antibodies that resulted would not block the HA protein, and the viruses would still be able to infect cells. Do you see the problem here? Vaccine manufacturers must stimulate the production of antibodies that attempt to block the proteins that viruses use to enter cells, or they would have zero effect.

Guess what, they still have zero effect because the proteins that most viruses use to enter cells are always changing. Pretty soon the light will come on for those still in the dark and show them that the protection is in immune cells, not antibodies. Immune cells can recognize many parts of the virus and stop the infection from happening right at the ephithelial barrier. Antibodies can’t do that. Worse, the injections retrain and focus the immune cells on what was injected rather than what exists in our environment, so any protection that was there is lost.

Many of the adverse reactions reported in the trial are a direct result of the immune system attacking and destroying cells that the HA protein attaches to. The HA protein attaches to sialic residues on red blood cells, the lining of blood vessel walls, the lining of the heart, some immune cells, and nerve cells. So, no wonder the adverse effects experienced in the vaccinated group included blood loss anemia, hematomas (capillary leaks), angina, cardiac arrest, congestive heart failure, myocardial infarction, atrial fibrillation, metabolic encephalopathy (brain dysfunction), pulmonary embolism, lymphadenopathy, tinnitus, and vertigo. None of those effects were seen in the placebo group.

All those nasty things happened, trying to prevent flu symptoms. Did it prevent flu symptoms? Nobody in the placebo group was diagnosed with the flu, whereas 7 people in the vaccinated group were officially diagnosed with the flu. One person in the placebo group experienced an undiagnosed influenza like illness, while 17 people in the vaccinated group got influenza like illnesses.

Not only did the injection not prevent flu like symptoms, but it also significantly weakened the immune system allowing the vaccinated person to experience other upper respiratory infections as well including COVID-19, RSV, and rhinovirus. The placebo group did not experience these other infections, other than one person diagnosed with asymptomatic COVID-19.

The results of the trial will be presented to VRBPAC and ACIP. The Vaccine and Related Biological Products Advisory Committee will advise the FDA to approve it, and the Advisory Committee on Immunization Practices will advise the CDC to put this poison on the childhood immunization schedule. There is no way to stop this from happening. Too much money is involved. Our only recourse is to educate ourselves and refuse it. We the people have the power to influence market demand and put these vaccine pushers out of business.

Thanks for reading, and thanks for staying smart.